RXSIGHT INC (RXST)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RXST
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RXST | Director | 42 | [] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| OFIX | Director | 41 | ["Healthcare/ MedTech Industry","Finance/Accounting","Global Business","Corporate Governance/ Legal","Operational Management","Corporate Responsibility","Compliance/ Quality / Regulatory","M&A","Sales & Marketing","Global Leader, Healthcare and Life Sciences Solutions and Strategy at Google Cloud","Director at SeaSpine since April 2021","Worked at Genentech leading market growth strategies","B.A. in Economics from the University of California, San Diego","Experience in medical devices and minimally invasive therapeutics","Thought leadership in enabling technologies and data analytics"] | ["Audit & Finance Committee","Compliance & Ethics Committee","Nominating, Governance & Sustainability Committee","Scientific Advisory Board"] | 2025 |
Biography sourced from the proxy statement filing.
Ms. Maniar joined our Board in December 2021, at which time she was nominated to serve as a member of the Governance Committee. Since July 2018, Ms. Maniar has served as Global Leader, Healthcare & Life Sciences Solutions & Strategy at Google, where she leads vision, strategy, and execution of Google Cloud's industry product strategy and go-to-market model. Prior to joining Google (Alphabet, Inc.) (NASDAQ: GOOG), from November 2013 to June 2018, Ms. Maniar contributed as an executive at Genentech, where she led market growth strategies relevant to technology accelerators for therapies and diagnostics. For more than a year previously, she served as Director for the Center of Minimally Invasive Therapeutics at Summa Health. Earlier in her career, Ms. Maniar spent several years in a research capacity at the Cleveland Clinic and the Austen BioInnovation Institute in Akron, where she was primarily focused on medical devices and minimally invasive therapeutics. She currently serves on the board of directors of Orthofix Medical Inc. (NASDAQ: OFIX). Ms. Maniar holds a B.A. in Economics from the University of California, San Diego. We believe Ms. Maniar is qualified to serve on our Board because of her leadership experience and her business, operations and strategy experience with healthcare companies.